Read More Economy ETFs Insight Markets Outlook Stocks Technical Analysis US Stocks Jurrien Timmer: Follow or Fade the Red Wave: Week of 11/11/24 by Jurrien Timmer, Director of Global Macro, Fidelity Investments What was anticipated to be a too-close-to-call election is… byFidelity Investments Canada
Read More ETFs Insight Markets Outlook Strategy Technical Analysis US Stocks USD The U.S. Dollar Reaches a Potential Inflection Point by Adam Turnquist, Chief Technical Strategist, LPL Research As the Election Day dust settles, the U.S. Dollar Index… byLPL Financial
Read More Economy ETFs Insight Markets Outlook Seasonality Strategy Technical Analysis US Stocks Brooke Thackray: How long can it last? by Brooke Thackray, Research Analyst, AlphaMountain Investments, Global X ETFs Let’s Talk About the U.S Election, without the… byAdvisorAnalyst
Read More Economy Inflation Insight Interest Rates Markets Monetary Policy Outlook US Stocks Politics, central banks, and what matters most to markets by Kristina Hooper, Chief Global Market Strategist, Invesco Key takeaways Stocks and elections - We’ve seen in the… byInvesco Canada
Read More Economy Insight Markets Outlook SIA Technical Analysis US Stocks Cheniere and Beyond: The Big Names Riding Natural Gas's Meteoric Rise by SIACharts.com Today's newsletter marks the first of what may be many discussions on the surging natural gas… bySIA Charts
Read More AI Artificial Intelligence ChatGPT ETFs Insight Markets Outlook Technology US Stocks CapEx: The Fuel Supply for the Artificial Intelligence Megatrend by Christopher Gannatti, CFA Global Head of Research, WisdomTree Key Takeaways The escalating capital expenditures of tech giants… byWisdomTree
Read More Emerging Markets ETFs Europe Global Investing Insight Markets Outlook US Stocks Global ETF trends to watch in 2025 by Jason Xavier, Head of EMEA & Asia ETF Capital Markets, Franklin Templeton Jason Xavier, Head of EMEA… byFranklin Templeton Investments
Read More Health Care Healthcare Insight Markets Outlook US Stocks Why Healthcare Investors Shouldn’t Bank on Drug Pipelines by Vinay Thapar, CFA, Co-Chief Investment Officer and Senior Research Analyst—US Growth Equities; Portfolio Manager—Global Healthcare, AllianceBernstein Healthcare… byAdvisorAnalyst